Pages that link to "Q71958937"
Jump to navigation
Jump to search
The following pages link to X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes (Q71958937):
Displaying 22 items.
- The causes and consequences of random and non-random X chromosome inactivation in humans (Q34120150) (← links)
- Clinical and genetic characterization of manifesting carriers of DMD mutations (Q34151973) (← links)
- The effects of low levels of dystrophin on mouse muscle function and pathology (Q34168463) (← links)
- Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype (Q34380291) (← links)
- X chromosome-inactivation patterns of 1,005 phenotypically unaffected females (Q35015824) (← links)
- Androgen receptor CAG repeats, non-random X chromosome inactivation, and loss of heterozygosity at Xq25 in relation to breast cancer risk (Q35104856) (← links)
- Exercise-induced left ventricular systolic dysfunction in women heterozygous for dystrophinopathy (Q35164387) (← links)
- Functional intergenic transcription: a case study of the X–inactivation centre (Q35213656) (← links)
- Familial Skewed X Inactivation: A Molecular Trait Associated with High Spontaneous-Abortion Rate Maps to Xq28 (Q35248996) (← links)
- Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy (Q36380483) (← links)
- Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. (Q37004830) (← links)
- Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age (Q37043820) (← links)
- Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers (Q37278457) (← links)
- Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy (Q38813192) (← links)
- Genetic control of X inactivation and processes leading to X-inactivation skewing. (Q42582301) (← links)
- Highly skewed inactivation of the wild-type X-chromosome in asymptomatic female carriers of spinal and bulbar muscular atrophy (Kennedy's disease). (Q46619367) (← links)
- Xite, X-inactivation intergenic transcription elements that regulate the probability of choice (Q48253132) (← links)
- Brief report: non-random X chromosome inactivation in females with autism. (Q50305534) (← links)
- X-chromosome inactivation patterns in females with Prader-Willi syndrome. (Q53594092) (← links)
- X-chromosome methylation ratios as indicators of chromosomal activity: evidence of intraindividual divergencies among tissues of different embryonal origin (Q71482721) (← links)
- Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study (Q77924716) (← links)
- Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology (Q92066121) (← links)